Half-life
6 days
Purity
≥ 99.84%
Mw
~4091–5135 g/mol
Retatrutide GLP-3 is a synthetic peptide that functions as a triple agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is primarily studied for its potential effects on glucose regulation, weight management, obesity treatment, and metabolic disorders in laboratory and in vitro settings.
MECHANISM OF ACTION
Retatrutide Triple agonist (GLP-1R, GIPR, GCGR); glucose-dependently enhances insulin secretion, suppresses glucagon/appetite via CNS, promotes lipolysis/energy expenditure, and delays gastric emptying in obesity, diabetes, and metabolic research models for superior weight loss/glycemic control.
SAME-DAY SHIP
COLD-CHAIN PACKAGED
COA AVAILABLE
